Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Tafasitamab for Children with Relapsed or Refractory Acute B Lineage Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on Hydroxycarbamide Tablets for Children with Sickle Cell Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    France
  • Study on the Effectiveness and Safety of Vedolizumab, Budesonide, and Prednisone for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Croatia Greece Hungary Italy Poland
  • Study on Long-Term Effects of Iptacopan in Patients with C3 Glomerulopathy or Idiopathic Immune-Complex Membranoproliferative Glomerulonephritis

    Recruiting

    3 1 1
    Investigated Diseases:
    Czechia France Germany Greece Italy The Netherlands +1
  • Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France Germany Italy The Netherlands Norway Spain +1
  • Study on Preventing Bleeding in Children with Severe von Willebrand Disease Using Vonicog Alfa and Octocog Alfa

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Ireland Italy Spain
  • Study on Sedation Effects of Dexmedetomidine vs. Midazolam in Mechanically Ventilated Preterm Infants

    Recruiting

    3 1 1 1
    Investigated Drugs:
    France
  • Study on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study on the Use of Fludeoxyglucose (18F) in PET/CT Scans for Young Patients with Histiocytosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Poland
  • Study on Vemurafenib for Children with BRAF Mutation-Resistant Histiocytosis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Poland